{"data":{"name":"com.phasefolio/phasefolio","title":null,"description":"Biotech rNPV/PoS engine for AI agents. Signed exports, evidence register, asset landscape.","version":"0.1.4","websiteUrl":"https://app.phasefolio.com","repositoryUrl":null,"remotes":[{"url":"https://app.phasefolio.com/api/mcp","type":"streamable-http","headers":[{"name":"Authorization","isSecret":true,"description":"Optional bearer token (Bearer pft_...) for org-scoped tools. Public tools work without auth."}]}],"packages":[{"version":"0.1.4","identifier":"@phasefolio/mcp","runtimeHint":"stdio","registryType":"npm","runtimeArguments":null,"environmentVariables":null}],"status":"active","isLatest":true,"publishedAt":"2026-05-03T08:52:53.515Z","updatedAt":"2026-05-03T08:52:53.515Z","source":"official-registry","verification":"official","confidence":100,"stars":null,"sources":[{"stars":null,"title":null,"source":"official-registry","sourceId":"com.phasefolio/phasefolio","updatedAt":"2026-05-03T08:52:53.515Z","confidence":100,"websiteUrl":"https://app.phasefolio.com","description":"Biotech rNPV/PoS engine for AI agents. Signed exports, evidence register, asset landscape.","verification":"official","repositoryUrl":null}],"toolIndex":{"tools":[{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"get_dossier","title":null,"description":"Fetch the structured asset snapshot JSON for a scenario — the same content rendered in the PDF/Excel exports, in machine-readable form. Includes verdict, drivers, assumptions, evidence summary, and (if available) signed-export hashes pointing to the latest signed artifacts.","inputSchema":{"type":"object","properties":{"scenario_id":{"type":"string","format":"uuid","pattern":"^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$","description":"UUID of the scenario to fetch the asset snapshot payload for."}},"required":["scenario_id"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Get Asset Snapshot","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"18669806b655228c103e0af9ead89249f2ee24fb54c4b759da0aa2870d9da8d1","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"get_evidence","title":null,"description":"Fetch the evidence register entries for a scenario — the citations, sources, and supporting documents the analyst attached to back the assumptions. Use this when an analysis question references 'what's the evidence for X?'","inputSchema":{"type":"object","properties":{"scenario_id":{"type":"string","format":"uuid","pattern":"^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$","description":"UUID of the scenario whose evidence register entries to fetch."}},"required":["scenario_id"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Get Evidence","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"3473263a945e9ef10552a59e8767f9d50a918a76881a0843df2b88b9a250a3c7","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"get_methodology","title":null,"description":"Fetch a PhaseFolio methodology section's full content (rNPV model, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, holding valuation, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.","inputSchema":{"type":"object","properties":{"section":{"type":"string","enum":["rnpv","backtest","pos-calibration","ira-framework","development-paths","deal-term-modelling","holding-valuation","stage-normalization","evidence-standards","network-benchmarks","cogs-benchmark","sga-benchmark","tax-benchmark","sec-deal-terms"],"description":"Which methodology section to fetch. 'rnpv' covers the core risk-adjusted NPV calculation: cumulative PoS, midpoint-discounted risk-adjusted development costs, the S-curve ramp/plateau/LOE revenue lifecycle net of COGS/SG&A/tax, WACC discounting, the rNPV and Unadjusted-NPV equations, Monte Carlo / expected NPV, and one-at-a-time sensitivity; 'backtest' covers the validation methodology and AUC/CI numbers; 'pos-calibration' covers the indication × modality × biomarker matrix, expanded modality normalization into the eight benchmark baselines, the scored multipliers including the model 2.6.0 biomarker_quality drug-specific multiplier (oncology solid tumor, Phase II/III), the Phase 1 ORR extracted-but-not-scored signal with its Phase 0 governance disclosure, and the non-scored drug-specific risk flags; 'ira-framework' covers the Year-9/Year-13 MFP cliff modeling and the separate IRA classification for expanded modalities such as RNA Therapeutics, Protein Degrader, Radioligand, Oncolytic Virus, and Cancer Vaccine; 'development-paths' covers development-path tiers, automatic-effect policy, and the no path-based PoS/default-multiplier rule; 'deal-term-modelling' covers how licensing deal terms map onto a scenario's deal structure (term-model mapping v1): what is modelled, not modelled and refused, the territory restriction and the approximations it names, milestone timing at stage ends, the cost-share rule, and the non-USD conversion-rate refusal; 'holding-valuation' covers how a Workspace holding is valued (scenario, share of asset value, look-through estimate, cost, not valued): each method's inputs, reason codes and completeness, the totals rules (never added across bases or currencies, estimates left out by default) and what the look-through estimate ignores; 'stage-normalization' covers exact clinical labels, work packages, canonical PoS gates, and the no label-only PoS modifier rule for Phase 1b/2a/2b, adaptive, pivotal, expansion, platform, bridging, and related labels; 'evidence-standards' covers source tiers and freshness rules; 'network-benchmarks' covers anonymization and cohort cuts; 'cogs-benchmark' covers the per-modality COGS% default bands and price-sensitivity methodology; 'sga-benchmark' covers the per-commercial-model SG&A% default bands (orphan/specialty/primary-care); 'tax-benchmark' covers the US-statutory-21% default tax rate, effective-rate reality, and the NOL cap; 'sec-deal-terms' is the retirement notice for the SEC EDGAR deal-term source (retired 2026-09-27), with its frozen versions."}},"required":["section"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Get Methodology Section","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"c38c013ad5b0a1b1406780a9b3af8302dfe0c33d3987da520f03d3a87c64b430","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"get_project","title":null,"description":"Fetch a PhaseFolio project's metadata: indication, sub-indication, modality, biomarker, asset name, and stage at entry. Use this when you need to ground an analysis question in the project's clinical context before fetching scenarios.","inputSchema":{"type":"object","properties":{"project_id":{"type":"string","format":"uuid","pattern":"^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$","description":"UUID of the PhaseFolio project. Get from the project URL in the dashboard or from a prior list_scenarios call."}},"required":["project_id"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Get Project","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"a7455144cc6043d2b3100bcd5ac00e2bade12a6b76302182b352bce25f4dfaca","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"get_scenario","title":null,"description":"Fetch a PhaseFolio scenario's complete inputs (stage costs, durations, PoS, commercial assumptions, IRA settings) and computed outputs (eNPV, rNPV, cumulative PoS, per-stage breakdown, top sensitivity drivers). This is the authoritative model output — every signed export ties back to this payload.","inputSchema":{"type":"object","properties":{"scenario_id":{"type":"string","format":"uuid","pattern":"^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$","description":"UUID of the scenario. Get from list_scenarios or the scenario URL in the dashboard."}},"required":["scenario_id"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Get Scenario","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"7c7634d2a53cc390bc1180575ee8a2d06deda89e59cb7814b40dab58e6c6986b","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"list_scenarios","title":null,"description":"List all scenarios in a PhaseFolio project. Returns scenario IDs, names, created/updated timestamps, and top-line eNPV/rNPV. Use this to discover what scenarios exist before fetching one in detail.","inputSchema":{"type":"object","properties":{"project_id":{"type":"string","format":"uuid","pattern":"^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$","description":"UUID of the parent project whose scenarios to list."},"limit":{"default":50,"description":"Maximum number of scenarios to return (1–200). Defaults to 50; raise for projects with many what-if branches.","type":"integer","minimum":1,"maximum":200}},"required":["project_id","limit"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"List Scenarios","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"85409a6a4d2ab5b9bc708e9841831085743cc27c9299ebbcd628716772685bd8","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"query_benchmarks","title":null,"description":"Query PhaseFolio benchmark availability. Source-backed PoS benchmarks are available separately; network cost distributions and duration percentiles are planned but currently return coming_soon with null estimates rather than PhaseFolio's manual planning defaults.","inputSchema":{"type":"object","properties":{"indication":{"type":"string","description":"Indication name (e.g. 'NSCLC', 'Rheumatoid Arthritis', 'Atopic Dermatitis'). Free-form; the model fuzz-matches to the canonical indication taxonomy."},"modality":{"description":"Optional modality filter ('Antibody', 'Small Molecule', 'Cell Therapy', 'Gene Therapy', etc.). Omit to return cross-modality stats.","type":"string"},"metric":{"type":"string","enum":["pos","cost","duration","all"],"description":"Which benchmark family to request. Cost and duration network benchmarks are currently coming_soon and return no estimate; manual wizard defaults are not returned as benchmarks."}},"required":["indication","metric"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Query Network Benchmarks","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"459fd3eb98c799635d0edb83163d45acf9b26634eec0b323550e5663872ac2a3","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"query_drug_risk","title":null,"description":"Fetch human-reviewed drug-specific clinical-risk signals for a project, including biomarker quality, Phase 1 ORR flag-only data, provenance, extractor versions, and pending-review counts. Use this before interpreting model 2.6.0 drug-specific multipliers or flags.","inputSchema":{"type":"object","properties":{"project_id":{"type":"string","format":"uuid","pattern":"^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$","description":"UUID of the project whose reviewed drug-specific clinical-risk signals should be queried."}},"required":["project_id"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Query Drug-Specific Risk","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"5696cecd8657896319ffec6a0cfc70f0f3b37ca8bd21541974a5d458dfe0100d","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"triage_asset","title":null,"description":"Produce a transparent, provenance-linked CONDITIONAL READ on a drug asset for deal triage. Pass either `text` (a teaser/abstract — fields are machine-extracted and the result is marked inputs_unconfirmed) or pre-confirmed `fields`. Returns a reasoning chain (each claim grounded or marked insufficient_evidence), mechanism-plausibility flags, PoS metrics, and a meta block with model/methodology/synthesis versions. Does NOT compute rNPV. Not an autonomous verdict.","inputSchema":{"type":"object","properties":{"text":{"description":"Unstructured asset text; triggers extraction (inputs_unconfirmed=true).","type":"string"},"fields":{"description":"Pre-confirmed structured fields.","type":"object","properties":{"modality":{"type":"string"},"target":{"type":"string"},"indication":{"type":"string"},"stage":{"type":"string"},"comparators":{"default":[],"type":"array","items":{"type":"string"}},"biomarker_strategy":{"default":"none","type":"string"}},"required":["modality","target","indication","stage","comparators","biomarker_strategy"],"additionalProperties":false}},"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Triage Asset","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"6e7ebe8cbd4902f10b95195251a9b516b23f73a7c4f1204b7c297f2d72f76941","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"},{"serverName":"com.phasefolio/phasefolio","endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","name":"verify_export","title":null,"description":"Verify a signed PhaseFolio export by content hash. Returns verification status (valid/tampered/unknown), issued timestamp, methodology version, and an anonymized originating-org identifier. Use this when a user shares a PhaseFolio asset snapshot and you want to confirm it's authentic before citing the analysis.","inputSchema":{"type":"object","properties":{"hash":{"type":"string","pattern":"^[a-f0-9]{64}$","description":"64-character hex SHA-256 of the signed artifact's content. Embedded in every signed PhaseFolio PDF (footer) and Excel (cover tab)."}},"required":["hash"],"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false},"annotations":{"title":"Verify Signed Export","readOnlyHint":true,"destructiveHint":false,"idempotentHint":true,"openWorldHint":true},"definitionHash":"29c659bc10b737c2f1297356efd2f7aa8897198abd04e0ad0324b08626c7f2a1","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T14:49:06.000Z","metadataTrust":"untrusted"}],"endpoints":[{"endpointFingerprint":"49b5f3c988f7bf3d5f8e2c1f74cd4fca4673b637e96e093109afafb633a49f77","protocol":"streamable-http","status":"indexed","toolCount":10,"observedAt":"2026-11-16T14:49:06.000Z"}],"authentication":"unknown"},"connectionConfigurations":{"status":"ready","authentication":"not embedded","clients":{"Claude Desktop":{"mcpServers":{"com.phasefolio/phasefolio":{"url":"https://app.phasefolio.com/api/mcp"}}},"Cursor":{"mcpServers":{"com.phasefolio/phasefolio":{"url":"https://app.phasefolio.com/api/mcp"}}},"VS Code":{"servers":{"com.phasefolio/phasefolio":{"type":"http","url":"https://app.phasefolio.com/api/mcp"}}}}},"resourceType":"mcp-server","callable":true,"runtime":{"callable":true,"protocols":["mcp"]},"interfaces":[{"protocol":"mcp","transport":"streamable-http","url":"https://app.phasefolio.com/api/mcp"},{"protocol":"mcp","package":"@phasefolio/mcp","registryType":"npm","version":"0.1.4"}],"profile":{"apiVersion":"1","schemaVersion":"1","id":"mcp-server:com.phasefolio%2Fphasefolio","resourceType":"mcp-server","canonicalUrl":"https://www.agentsjunction.com/api/v1/servers/com.phasefolio%2Fphasefolio","name":"com.phasefolio/phasefolio","description":"Biotech rNPV/PoS engine for AI agents. Signed exports, evidence register, asset landscape.","interfaces":[{"protocol":"mcp","transport":"streamable-http","url":"https://app.phasefolio.com/api/mcp"},{"protocol":"mcp","package":"@phasefolio/mcp","registryType":"npm","version":"0.1.4"}],"capabilities":[],"identity":{"source":"official-registry","websiteUrl":"https://app.phasefolio.com","repositoryUrl":null,"version":"0.1.4"},"verification":{"state":"official","confidence":100},"operations":{"resourceType":"mcp-server","name":"com.phasefolio/phasefolio","status":"online","lastCheckedAt":"2026-11-20T07:17:09.153Z","lastSuccessfulCheck":"2026-11-20T07:17:09.153Z","latencyMs":169,"consecutiveFailures":0,"isStale":false,"checks":{"endpointReachable":true,"protocolValid":true,"agentCardValid":null,"mcpHandshakeValid":true},"lastSeen":null,"lastSuccessfulInteraction":null,"lastHealthCheck":"2026-11-20T07:17:09.153Z","source":{"type":"health-check","url":null},"observedAt":"2026-11-20T07:17:09.153Z"},"security":null,"timestamps":{"createdAt":"2026-05-03T08:52:53.515Z","updatedAt":"2026-05-03T08:52:53.515Z","observedAt":"2026-11-20T07:17:09.153Z"},"compatibility":{"serverVersion":"0.1.4","protocolVersions":[{"protocol":"mcp","version":null}]}}}}